The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin
Open Access
- 1 July 1995
- journal article
- research article
- Published by Wiley in Liver Transplantation and Surgery
- Vol. 1 (4), 249-255
- https://doi.org/10.1002/lt.500010410
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Recent advances in ultrasonographic diagnosis of hepatocellular carcinomaCancer, 1989
- Increased serum ferritin in chronic liver disease: A risk factor for primary hepatocellular carcinomaInternational Journal of Cancer, 1989
- Production of abnormal prothrombin (des-γ-carboxy prothrombin) by hepatocellular carcinoma: A clinical and experimental studyJournal of Hepatology, 1987
- Follow-up study of 582 liver cirrhosis patients for 26 years in JapanLiver International, 1987
- Primary liver cancer in Japan. Sixth reportCancer, 1987
- The value of serum concentrations of tissue polypeptide antigen in the diagnosis of hepatocellular carcinomaCancer, 1986
- Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virusJAMA, 1985
- Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular CarcinomaThe New England Journal of Medicine, 1984
- Serum ferritin and binding of serum ferritin to concanavalin A as a tumor marker in patients with primary liver cell cancer and chronic liver diseaseDigestive Diseases and Sciences, 1982
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973